logo for Intercept Pharmaceuticals

Intercept Pharmaceuticals - Business Information

Manufacturing · New Jersey, United States · 341 Employees

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid (OCA), a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). The company is developing OCA to treat various non-viral progressive liver diseases, such as nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. It also provides OCA under the Ocaliva brand name for the treatment of primary biliary cholangitis in the United States and Europe. In addition, the company is developing INT-767, an orally administered dual FXR and TGR5 agonist for the treatment of liver fibrosis; and INT-777, an orally administered TGR5 agonist for the treatment of type 2 diabetes, associated metabolic disorders, and other gastrointestinal indications. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New...Read More

View Company Info for Free

Who is Intercept Pharmaceuticals

Intercept Pharmaceuticals Headquarters

Headquarters

305 Madison Ave, Morristown, New Jersey, 07960, United States
Phone Number

Phone Number

(646) 747-1000
Intercept Pharmaceuticals Revenue

Revenue

$285.7M
Stock Symbol

Stock Symbol

ICPT
Industry

Industry

PharmaceuticalsHealthcareIntercept Pharmaceuticals's Social MediaPopular SearchesIntercept Pharmaceuticals IncInterCept IncIntercept PharmaceuticalsIntercept Technology IncInterceptSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ICPTShow More

Top Competitors of Intercept Pharmaceuticals

Intercept Pharmaceuticals Org Chart

View Intercept Pharmaceuticals org chart to access information on key employees and get valuable insights about Intercept Pharmaceuticals organizational structure. The organizational chart highlights the reporting lines within the company, starting with Raffi Alexanian - the Intercept Technologies Founder & Chief Executive Officer of Intercept Pharmaceuticals, and followed by additional decision makers: Anindita Sinha, Vice President, Chief of Staff To the Chief Executive Officer, and Rachel Bernard, Vice President Chief Of Staff Office Of The Chief Executive Officer.
Raffi Alexanian
Raffi Alexanian

Intercept Technologies Found...

PhonePhoneEmailEmail
Anindita Sinha
Anindita Sinha

Vice President, Chief of Sta...

PhonePhoneEmailEmail
Rachel Bernard
Rachel Bernard

Vice President Chief Of Staf...

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Intercept Pharmaceuticals Email

Intercept Pharmaceuticals Company Metrics

Company Insights
Company Insights
Employee Growth Rate
Employee Growth Rate
Intercept Pharmaceuticals Funding
Funding
Funding DateMay 10, 2019
RoundStock Issuance/Offering
Amount$200M
Investors
Funding DateMay 10, 2019
RoundDebt
Amount$210.4M
Investors
Funding DateApr 05, 2018
RoundStock Issuance/Offering
Amount$250M
InvestorsSamsara BioCapital, L.P., Genextra S.p.A
See More

$1.5B

Total Funding Amount

$200M

Most Recent Funding Amount

11

Number of Funding Rounds

Top Companies in United States

View leading companies in United States by different categories: revenue, number of employees and funding amount. Top companies in United States by revenue is Walmart, by number of employees is Tip Top Poultry and by funding amount is American Airlines. See full lists for all leading companies and additional company information such as contact details, org chart, industry, employees and more.

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Intercept Pharmaceuticals News & Media

Read more news

Frequently Asked Questions regarding Intercept Pharmaceuticals

Where is Intercept Pharmaceuticals located?
Intercept Pharmaceuticals's headquarters are located at 305 Madison Ave, Morristown, New Jersey, 07960, United States
What is Intercept Pharmaceuticals's phone number?
Intercept Pharmaceuticals's phone number is (646) 747-1000
What is Intercept Pharmaceuticals's stock symbol?
Intercept Pharmaceuticals's stock symbol is ICPT
What is Intercept Pharmaceuticals's official website?
Intercept Pharmaceuticals's official website is www.interceptpharma.com
What is Intercept Pharmaceuticals's Revenue?
Intercept Pharmaceuticals's revenue is $285.7 Million
What is Intercept Pharmaceuticals's SIC code?
Intercept Pharmaceuticals's SIC: 28,283
What is Intercept Pharmaceuticals's NAICS code?
Intercept Pharmaceuticals's NAICS: 32,325
How many employees does Intercept Pharmaceuticals have?
Intercept Pharmaceuticals has 341 employees
What industry does Intercept Pharmaceuticals belong to?
Intercept Pharmaceuticals is in the industry of: Pharmaceuticals, Healthcare
What is Intercept Pharmaceuticals competition?
Intercept Pharmaceuticals top competitors include: Atara Biotherapeutics, Global Blood Therapeutics, Epizyme Inc, Ascentage Pharma
Who is the CEO of Intercept Pharmaceuticals?
Intercept Pharmaceuticals's CEO is Jerome Durso
Who is the CFO of Intercept Pharmaceuticals?
Intercept Pharmaceuticals's CFO is Andrew Saik
How do I contact Intercept Pharmaceuticals?
Intercept Pharmaceuticals contact info: Phone number: (646) 747-1000 Website: www.interceptpharma.com
What does Intercept Pharmaceuticals do?

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid (OCA), a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and ac... tivates the farnesoid X receptor (FXR). The company is developing OCA to treat various non-viral progressive liver diseases, such as nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. It also provides OCA under the Ocaliva brand name for the treatment of primary biliary cholangitis in the United States and Europe. In addition, the company is developing INT-767, an orally administered dual FXR and TGR5 agonist for the treatment of liver fibrosis; and INT-777, an orally administered TGR5 agonist for the treatment of type 2 diabetes, associated metabolic disorders, and other gastrointestinal indications. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New...Read More

What are Intercept Pharmaceuticals social media links?
Intercept Pharmaceuticals Linkedin page Intercept Pharmaceuticals Facebook page Intercept Pharmaceuticals Twitter page
How much funding has Intercept Pharmaceuticals raised to date?
Intercept Pharmaceuticals has raised $1.5 Billion in 11 funding rounds
When was the last funding round for Intercept Pharmaceuticals?
Intercept Pharmaceuticals closed its last funding round on May 10, 2019 with the amount of $200 Million
Who invested in Intercept Pharmaceuticals?
Intercept Pharmaceuticals has 15 investors including JAFCO Life Science Investment, Genextra S.p.A, Balyasny Asset Management and Rodman & Renshaw.
Is Intercept Pharmaceuticals a public company?
Yes, Intercept Pharmaceuticals is a public company and is traded under the symbol ICPT
See more information about Intercept Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.